Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: Analysis by COBAS TaqMan real-time PCR

Intervirology

Volumn 50, Issue 4, 2007, Pages 241-244

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Kiriyama, Seiki ^a   Sone, Yasuhiro ^a   Tanikawa, Makoto ^a   Hisanaga, Yasuhiro ^a   Kanamori, Akira ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

COBAS TaqMan HBV test; HBV DNA, circulating low level; HBV surface antigen negative; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIREMIA;

AGED; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; TAQ POLYMERASE; VIREMIA;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 34447628869     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101911     Document Type: Article

References (17)

1. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P: Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 2001;34:194-203.
2. Hu KQ: Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002;9:243-257.
3. Torbenson M, Thomas DL: Occult hepatitis B. Lancet Infect Dis 2002;2:479-486.
4. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G: Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004;126:102-110.
5. Sum SSM, Wong DKH, Yuen JCH, Lai CL, Yuen MF: Comparison of the COBAS TaqMan HBV test with the COBAS Amplicor Monitor test for measurement of hepatitis B virus DNA in serum. J Med Virol 2005;77:486-490.
6. Weiss J, Wu H, Farrenkopf B, Schultz T, Song G, Shah S, Siegel J: Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol 2004;30:86-93.
7. Coursaget P, Le Cann P, Leboulleux D, Diop MT, Bao O, Coll AM: Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Lett 1991;83:35-38.
8. Sheu JC, Huang GT, Shih LN, Lee WC, Chou HC, Wang JT, Lee PH, Lai MY, Wang CY, Yang PM, Lee HS, Chen DS: Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-1327.
9. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Brechot C: Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-29.
10. Enriquez J, Fuchs K, Martinez Cerezo FJ, Seminago R, Madoz P, Torras J, Roggendorf M: Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinoma. Eur J Epidemiol 1994;10:189-194.
11. Brechot C, Jaffredo F, Lagorce D, Gerken G, zum Buschenfelde KM, Papakonstontinou A, Hadziyannis S, Romeo R, Colombo M, Rodes J, Bruix J, Williams R, Naoumov N: Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinoma in Europe: results of a European concerted action. J Hepatol 1998;29:173-183.
12. Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M: The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. J Exp Clin Cancer Res 1999;18:379-389.
13. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H: Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000;62:151-158.
14. Yotsuyanagi H, Shintani Y, Moriya K, Fujie H, Tsutsumi T, Kato T, Nishioka K, Takayama T, Makuuchi M, Iino S, Kimura S, Koike K: Virologic analysis of non-B, non-C, hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000;181:1920-1928.
15. Kao JH, Chen PJ, Lai MY, Chen DS: Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002;40:4068-4071.
16. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002;62:S8-S17.
17. Hochberger S, Althof D, Gallegos de Schrott R, Nachbaur N, Rock H, Leying H: Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 2006;35:373-380.